368 related articles for article (PubMed ID: 35884903)
1. Metal-Based Nanostructured Therapeutic Strategies for Glioblastoma Treatment-An Update.
Gawel AM; Singh R; Debinski W
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884903
[TBL] [Abstract][Full Text] [Related]
2. Potential of Nanocarrier-Associated Approaches for Better Therapeutic Intervention in the Management of Glioblastoma.
Vikram ; Kumar S; Ali J; Baboota S
Assay Drug Dev Technol; 2024; 22(2):73-85. PubMed ID: 38193798
[No Abstract] [Full Text] [Related]
3. Lipid-Based Nanocarriers in the Treatment of Glioblastoma Multiforme (GBM): Challenges and Opportunities.
Gupta T; Sahoo RK; Singh H; Katke S; Chaurasiya A; Gupta U
AAPS PharmSciTech; 2023 Apr; 24(4):102. PubMed ID: 37041350
[TBL] [Abstract][Full Text] [Related]
4. Advances in Glioblastoma Therapy: An Update on Current Approaches.
Angom RS; Nakka NMR; Bhattacharya S
Brain Sci; 2023 Oct; 13(11):. PubMed ID: 38002496
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.
Wiwatchaitawee K; Quarterman JC; Geary SM; Salem AK
AAPS PharmSciTech; 2021 Feb; 22(2):71. PubMed ID: 33575970
[TBL] [Abstract][Full Text] [Related]
6. Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide.
Sukumar UK; Bose RJC; Malhotra M; Babikir HA; Afjei R; Robinson E; Zeng Y; Chang E; Habte F; Sinclair R; Gambhir SS; Massoud TF; Paulmurugan R
Biomaterials; 2019 Oct; 218():119342. PubMed ID: 31326657
[TBL] [Abstract][Full Text] [Related]
7. Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment.
Pinel S; Thomas N; Boura C; Barberi-Heyob M
Adv Drug Deliv Rev; 2019 Jan; 138():344-357. PubMed ID: 30414495
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine associated with photodynamic therapy for glioblastoma treatment.
de Paula LB; Primo FL; Tedesco AC
Biophys Rev; 2017 Oct; 9(5):761-773. PubMed ID: 28823025
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles for hyperthermic therapy: synthesis strategies and applications in glioblastoma.
Verma J; Lal S; Van Noorden CJ
Int J Nanomedicine; 2014; 9():2863-77. PubMed ID: 24959075
[TBL] [Abstract][Full Text] [Related]
10. Theranostic nanoparticles enhance the response of glioblastomas to radiation.
Wu W; Klockow JL; Mohanty S; Ku KS; Aghighi M; Melemenidis S; Chen Z; Li K; Morais GR; Zhao N; Schlegel J; Graves EE; Rao J; Loadman PM; Falconer RA; Mukherjee S; Chin FT; Daldrup-Link HE
Nanotheranostics; 2019; 3(4):299-310. PubMed ID: 31723547
[TBL] [Abstract][Full Text] [Related]
11. Ligand-Mediated and Enzyme-Directed Precise Targeting and Retention for the Enhanced Treatment of Glioblastoma.
Ruan S; Xiao W; Hu C; Zhang H; Rao J; Wang S; Wang X; He Q; Gao H
ACS Appl Mater Interfaces; 2017 Jun; 9(24):20348-20360. PubMed ID: 28557433
[TBL] [Abstract][Full Text] [Related]
12.
Gallego L; Ceña V
Expert Opin Drug Deliv; 2020 Nov; 17(11):1541-1554. PubMed ID: 32791861
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update.
Hsu JF; Chu SM; Liao CC; Wang CJ; Wang YS; Lai MY; Wang HC; Huang HR; Tsai MH
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33430494
[TBL] [Abstract][Full Text] [Related]
14. Magnetic targeting of paclitaxel-loaded poly(lactic-
Ganipineni LP; Ucakar B; Joudiou N; Bianco J; Danhier P; Zhao M; Bastiancich C; Gallez B; Danhier F; Préat V
Int J Nanomedicine; 2018; 13():4509-4521. PubMed ID: 30127603
[TBL] [Abstract][Full Text] [Related]
15. Design of new protein drug delivery system (PDDS) with photoactive compounds as a potential application in the treatment of glioblastoma brain cancer.
de Melo MT; Piva HL; Tedesco AC
Mater Sci Eng C Mater Biol Appl; 2020 May; 110():110638. PubMed ID: 32204072
[TBL] [Abstract][Full Text] [Related]
16. A gain of function paradox: Targeted therapy for glioblastoma associated with abnormal NHE9 expression.
Pall AE; Juratli L; Guntur D; Bandyopadhyay K; Kondapalli KC
J Cell Mol Med; 2019 Nov; 23(11):7859-7872. PubMed ID: 31532058
[TBL] [Abstract][Full Text] [Related]
17. Induction Therapy of Retinoic Acid with a Temozolomide-Loaded Gold Nanoparticle-Associated Ultrasound Effect on Glioblastoma Cancer Stem-Like Colonies.
Fadera S; Chen PY; Liu HL; Lee IC
ACS Appl Mater Interfaces; 2021 Jul; 13(28):32845-32855. PubMed ID: 34235925
[TBL] [Abstract][Full Text] [Related]
18. Enhancing the efficacy of drug-loaded nanocarriers against brain tumors by targeted radiation therapy.
Baumann BC; Kao GD; Mahmud A; Harada T; Swift J; Chapman C; Xu X; Discher DE; Dorsey JF
Oncotarget; 2013 Jan; 4(1):64-79. PubMed ID: 23296073
[TBL] [Abstract][Full Text] [Related]
19. Targeting Non-coding RNA for Glioblastoma Therapy: The Challenge of Overcomes the Blood-Brain Barrier.
Sharma RK; Calderon C; Vivas-Mejia PE
Front Med Technol; 2021; 3():678593. PubMed ID: 35047931
[TBL] [Abstract][Full Text] [Related]
20. Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers.
Delello Di Filippo L; Hofstätter Azambuja J; Paes Dutra JA; Tavares Luiz M; Lobato Duarte J; Nicoleti LR; Olalla Saad ST; Chorilli M
Eur J Pharm Biopharm; 2021 Nov; 168():76-89. PubMed ID: 34461214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
